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Background: Inclusion bodies (IBs) were generally considered to be inactive protein deposits and did not hold any
attractive values in biotechnological applications. Recently, some IBs of recombinant proteins were confirmed to
show their functional properties such as enzyme activities, fluorescence, etc. Such biologically active IBs are not
commonly formed, but they have great potentials in the fields of biocatalysis, material science and
nanotechnology.
Results: In this study, we characterized the IBs of DL4, a deletion variant of green fluorescent protein which forms
active intracellular aggregates. The DL4 proteins expressed in Escherichia coli were exclusively deposited to IBs, and
the IBs were estimated to be mostly composed of active proteins. The spectral properties and quantum yield of the
DL4 variant in the active IBs were almost same with those of its native protein. Refolding and stability studies
revealed that the deletion mutation in DL4 didn’t affect the folding efficiency of the protein, but destabilized its
structure. Analyses specific for amyloid-like structures informed that the inner architecture of DL4 IBs might be
amorphous rather than well-organized. The diameter of fluorescent DL4 IBs could be decreased up to 100–200 nm
by reducing the expression time of the protein in vivo.
Conclusions: To our knowledge, DL4 is the first GFP variant that folds correctly but aggregates exclusively in vivo
without any self-aggregating/assembling tags. The fluorescent DL4 IBs have potentials to be used as fluorescent
biomaterials. This study also suggests that biologically active IBs can be achieved through engineering a target
protein itself.
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Production of heterologous proteins in bacterial cells
often results in the formation of inclusion bodies (IBs),
pseudo-spherical particles with size ranging from nano-
meter to micrometer in diameter [1]. In general, IBs are
misfolded and inactive protein deposits, which have
been considered to be the waste by-product of protein
expression [2,3]. A number of studies were carried out
to prohibit the formation of IBs in the process of target
protein production. For instance, control of target pro-
tein expression rate, engineering of target protein, and
co-expression of molecular chaperones were effective in
the suppression of IBs formation [4,5].* Correspondence: sungulee@pusan.ac.kr
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article, unless otherwise stated.Recently, the understanding of IBs has been completely
changed. IBs of some recombinant proteins were demon-
strated to be active, and their biotechnological applications
were suggested. For instance, the IBs of enzymes such
as amidase, acylphosphatase, and D-amino acid oxidase
showed catalytic activities [6-9]. The active enzyme IBs
are promising in industrial biotransformation because
they can be easily recovered and reused. Other examples
include the functional IBs for diagnosis, tissue engineering
and for nano-medicines [10-12]. These examples evidently
indicate the importance and potentials of active IBs for
research and industrial applications.
Green fluorescent protein (GFP) belongs to a family of
fluorescent proteins, functionally active if the β-barrel
structure composed of 11 β-stands and a single central
helix is properly formed [13]. The folding efficiency of
wild-type GFP was very low, and hence its productionentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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misfolded proteins [14]. The engineering of its sequence
permitted the generation of various GFP mutants which
fold more efficiently to be its active form [15]. Indeed,
such GFP variants with high folding efficiency have been
widely employed in various scientific and technological
fields. On the other hand, recent studies demonstrated
that it was possible to achieve biologically active fluores-
cent IBs of GFP. General GFP IBs exhibited fluorescence
because properly folded active proteins were included in
the aggregation process of misfolded protein molecules
[14]. The formation of active GFP IBs could be further
induced by expressing the GFP fused to self-aggregating/
assembling peptide or protein sequences [16-19]. It
was proposed that such active IBs of GFP could be a
good precursor for the preparation of fluorescent
biomaterials [20,21].
In our recent study, various GFP deletion mutants were
generated based on the structurally stabilized GFP [22]. In
the process of screening functional deletion mutants, we
serendipitously discovered that DL4, a mutant devoid of
an internal loop region, showed high fluorescent activity
in the insoluble fraction of cell lysates. This made us to
speculate that the deletion may induce the intracellular
aggregation of folded DL4 leading to formation of active
GFP IBs. Here, the hypothesis was demonstrated by
executing various analytical studies. Expression study and
confocal microscope analysis confirmed that DL4 was ex-
clusively deposited to IBs in E. coli cytoplasm and the IBs
were mostly composed of active proteins. We also investi-
gated various biophysical properties of the DL4 active IBs
such as spectral characteristics, refolding kinetics, thermal
stability, and amyloid-like structural property. Finally, an
attempt to prepare fluorescent protein nanoparticles
was made by controlling the size of fluorescent DL4 IBs
in vivo.
Methods
Expression and purification of proteins and IBs
The genes encoding DL4 or GFP-hs1 cloned in pET30b
(+) were expressed in E .coli BL21 (DE3) as previously
[22]. The soluble protein fraction of GFP-hs1 was purified
by Ni-NTA column chromatography (GE Healthcare Bio-
Sciences, Sweden) by using the standard protocol. The IBs
of DL4 were purified as per the modified protocol based
on previous procedures [23,24]. Cells were lysed by os-
motic lysis with Tris-sucrose buffer (50 mM Tris, 735 mM
sucrose, 1 mM EDTA, 0.1% sodium azide, 10 mM DTT,
pH 8.0) and the lysate was clarified by centrifuging at
6200 g for 10 min. The insoluble pellet was resuspended
in Tris buffer (50 mM Tris, 200 mM sodium chloride,
pH 8.0) containing DNase (10 μg/ml), lysozyme (0.2 mg/ml),
1 mM PMSF (phenylmethanesulfonylfluoride) and incu-
bated at 37°C for 30 min. The lysate was centrifuged at15000 g for 10 min and the pellet was resuspended in
washing buffer (50 mM Tris, 50 mM sodium chloride,
1% Triton X-100, 1 M urea, 1 mM EDTA, pH 8.0). The
suspension was centrifuged at 15000 g for 10 min and
the detergent was removed by washing with sterile distilled
water and then with the Tris buffer. Finally the purified
IBs were stored at −20°C for later use.
SDS-PAGE analysis
The overexpressed cells were harvested with cell density
of 3.0 O.D600nm by centrifuging at 1200 g for 10 min at
4°C. The cell pellets were resuspended in 50 mM Tris
buffer (pH8.0), and lysed by French press. The soluble
fraction clarified from insoluble fractions was separated
by centrifuging the cell lysate at 3700 g for 30 min, and
the soluble and insoluble fractions were analyzed by 12%
SDS-PAGE using standard protocol.
Analyses of fluorescent spectral properties, refolding
kinetics and stability
The fluorescence was recorded using Perkin Elmer/Wallac
Victor 2 Multilabel Counter (1420–011) with excitation
and emission at 485 nm and at 515 nm respectively. To
determine the specific fluorescence activities of the
GFP-hs1 and DL4, the protein concentrations of puri-
fied GFP-hs1 and DL4 in the purified IBs were esti-
mated by Bradford’s method and known amounts of
the samples were used for the measurement of fluores-
cence. The ex/em spectra were scanned using Hitachi
fluorescence spectrophotometer F-7000 as previously
reported [22]. The relative quantum yield of GFP-hs1
and DL4 were estimated by comparing their fluores-
cence with fluorescein (Sigma) as reference standard in
0.1 M Tris (pH 8.0). The samples and standard fluores-
cein (0.92) were diluted in 0.1 M Tris buffer to prepare
solution of equal absorbance. The emission spectra
were recorded by exciting at 490 nm, from 450 nm to
650 nm at a scan speed of 240 nm/min with ex/em slit
of 5 nm. The integrated fluorescence intensity was
calculated from the emission spectra and the relative
quantum yield was calculated as previously described
[25]. The refolding kinetics of the GFP-hs1 was mea-
sured as reported previously [22]. For refolding plot of
DL4, the purified DL4 IBs were denatured with 8 M
urea by incubating in boiling water for 5 min and im-
mediately refolding was initiated by rapid dilution with
1X phosphate buffered saline (PBS) (pH 7.4). To assess
the thermal stability of GFP variants, protein samples
were incubated at different temperatures from 70°C to
90°C at 5°C intervals for 30 min and the remaining
fluorescence was recorded. For time-dependent assay,
protein samples were incubated at 80°C for 40 min
with 10 min time intervals and the remaining fluorescence
was recorded.
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The E. coli expressing DL4 mutant and GFP-hs1 were
grown at 37°C till mid-log phase and induced with
0.5 mM IPTG for 5 hours. 200 μl of the cells were har-
vested, centrifuged at 1200 g for 5 min and resuspended
in 200 μl of 1X PBS. The cells were then fixed on
glass slide with freshly prepared 4% paraformaldehyde
(dissolved in PBS), then washed with 1X PBS and cover
slip was placed for samples to be observed. The images
were photographed at 488 nm using Plan-Apochromat
objective (100X, NA 1.4 oil) in Zeiss LSM 510 confocal
microscope (Carl Zeiss, Germany). The resulting image
was analyzed using the color palette option in the Zeiss
LSM image examiner.
The thioflavin T assay, proteolytic digestion, and electron
microscopy for IBs
Purified DL4 IBs were tested by thioflavin-T (ThT) binding
assay in Tris-NaCl buffer (pH8.0). The reaction was carried
out by incubating IBs in 25 μM of ThT and the emission
was recorded after exciting at 450 nm. The amyloidogenic
protein bound with ThT dye will give emission maxima
at 480 nm [26,27]. Proteolytic digestion and electron
microscope analysis of the purified IBs were carried out
based on the reported methods [28,29]. The IBs diluted
20 times in Tris-NaCl buffer were treated with protein-
ase K (20 μg/ml) and digested overnight at 37°C. The
solution was briefly centrifuged at maximum speed and
the pellet was resuspended in distilled water. To observe
under electron microscope, the sample was placed on
carbon coated copper grid for 5 min at room temperature.
The grid was rinsed with 10 μl of distilled water for 2 min
and then the negative staining was done with 2% uranyl
acetate for 1 min. After blotting and air drying, the elec-
tron micrograph images of inclusion bodies were captured
using Hitachi transmission microscope (H-7600).
Determination of particle size by light scattering
The size distribution of IBs was studied by dynamic light
scattering using 90 Plus, Particle Size Analyzer, Brookhaven
Instruments Corporation. Purified IBs suspended in
50 mM Tris (pH8.0) were sonicated for 1 min at room
temperature. The samples were diluted 100 fold in the
same buffer and the measurement was recorded at 25°C
with dust filter turned on.
Results
Active IB formation of DL4 in vivo
The GFP mutant termed “DL4” was generated based on
GFP-hs1, a GFP variant with high folding robustness
and stability. The remarkably stable structure of GFP-hs1
was expected to be beneficial in tolerating for various mu-
tations, which motivated us to construct various deletion
mutations of GFP-hs1. It was possible to delete someinternal loop sequences of GFP-hs1 without abolishing
its folding and fluorescent activity, whereas those deletions
led to the misfolding of normal GFP. Expression studies
were carried out for the active deletion variants, which
revealed that most of them were expressed as soluble
forms. Unexpectedly, one variant (DL4) devoid of ex-
posed loop sequence (191-GPVLLP-196) was identified
to be expressed as insoluble forms with fluorescent ac-
tivities. The primary structure of GFP-hs1 and DL4
were presented in supplementary material, Additional
file 1: Figure S1. More details were described in our
previous report [22].
The unexpected observation that DL4 showed insoluble
but fluorescent expression motivated us to check the pos-
sibility of the formation of active IBs. First, a study on the
expression pattern of the DL4 was performed in detail.
When GFP-hs1 and DL4 were expressed at 37°C in E. coli
and their cell lysates were analyzed, DL4 protein was ex-
clusively found in insoluble fraction with traces of DL4 in
its soluble fraction, whereas GFP-hs1 was mostly found in
the soluble fraction (Figure 1A). The specific fluorescence
activities of the soluble and insoluble fractions of GFP-hs1
and DL4 also confirmed that the expressed DL4 was
exclusively deposited into insoluble fraction in its highly
active form, whereas active GFP-hs1 was expressed as sol-
uble forms (Figure 1B). The specific fluorescent activities
of GFP-hs1 and DL4 were almost negligible in their insol-
uble fractions and soluble fractions, respectively. The
lower specific fluorescence activity of the GFP-hs1 in
soluble fraction compared to the insoluble deposits of
DL4 might be due to the presence of other cellular pro-
teins in soluble fraction of GFP-hs1. To check whether
the exclusive deposition of DL4 into insoluble fraction
occurred right after in vivo protein translation or during
the process of cell lysis, the intracellular states of DL4 and
GFP-hs1 were investigated by in vivo image analysis with
laser scanning confocal microscope. As shown in Figure 2,
DL4 was observed as a dense fluorescent aggregates and it
was confined to one corner of the bacterial cell. On the
other hand, the control protein, GFP-hs1, was spread
throughout the cytoplasm of the bacterial cell without
any particulate morphology. The image analysis with
fluorescence intensity color palette also showed the
distinct difference in distribution of proteins between
the GFP-hs1 and DL4. These results clearly indicated
that the aggregation of DL4 occurred in bacterial cell
after the protein translation and folding, confirming
that the DL4 was exclusively expressed as intracellular
active IBs in E. coli.
Fluorescent properties of DL4 IBs
Next study was to examine the fluorescent properties of
DL4 proteins in the IBs such as excitation/emission
wavelength, quantum yield and specific fluorescent activity.
Figure 1 Expression and functional analysis of GFP-hs1 and DL4. (A) Soluble and insoluble expression profiles of GFP-hs1 and DL4 by
SDS-PAGE. M – Marker, Lane 1,3 - soluble fractions of GFP-hs1 & DL4, Lane 2,4 – insoluble fractions of GFP-hs1 & DL4. (B) Specific fluorescence
activities of DL4 and GFP-hs1 in their soluble and insoluble fractions. Specific fluorescence activity is defined as the fluorescence per microgram
of protein. The values are the average of three measurements and standard deviations are shown.
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information. First was the effect of deletion mutations on
the structural properties of GFP. The fluorescent proper-
ties of GFP are known to be very sensitive to the structural
perturbation around active site of the protein, and can beFigure 2 In vivo analysis of IBs formation. (Top) Analysis of protein distr
observed as dense molecules forming localized pattern of distribution (DL4
the cytoplasm (GFP-hs1). Scale bar represents 2 μm. (Bottom) The green flu
high (red).used to probe the structural changes induced by muta-
tions [13]. Second, the portion of active DL4 in the IBs,
presumed to be highly dominant, would be more exactly
estimated by comparing the spectral properties of DL4 IBs
with GFP-hs1.ibutions in E. coli using confocal microscope. Protein aggregates were
) whereas the expression of soluble protein was spread uniformly over
orescence intensity mapped in color scale from low (blue) to
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the representative intrinsic spectral properties of fluores-
cent proteins were estimated for the purified IBs of DL4,
and they were compared with those of purified GFP-hs1.
The spectral maxima for the excitation and emission were
scanned for DL4 and GFP-hs1 (Figure 3), and both
proteins showed almost similar fluorescent spectra with
maxima ex/em at 490/511 nm (Table 1). The quantum
yield of DL4 was determined to be about 0.33, also compar-
able value to GFP-hs1 (Table 1). These results indicated
that the intrinsic spectral properties of GFP-hs1 were not
affected by the deletion of 191–196 loop sequence. As
mentioned above, the fluorescent properties such as
ex/em wavelength and quantum yield are generally affected
by the global GFP structure. Therefore, our results
indirectly indicated that the DL4 structure may not be
significantly different from its native form.
The same fluorescent properties of DL4 and GFP-hs1
implied that the portion of the active DL4 proteins in
the IBs can be estimated simply by comparing the specific
fluorescence activity of purified DL4 IBs and that of puri-
fied GFP-hs1. The specific fluorescent activity of DL4 IBs
was determined to be approximately 95% of GFP-hs1
(Table 1). Because the purified DL4 IBs were evaluated to
include only DL4 variants by SDS-PAGE analysis (data
not shown), this result indicated that the DL4 IBs was
mostly composed of active DL4 proteins and the propor-
tion of inactive DL4 proteins was negligible.
Refolding kinetics and thermal stability of DL4
GFP-hs1, the template used for generating the DL4
variant, was constructed based on the previously reported
mutations which were known to enhance the folding andFigure 3 Excitation/emission spectra of GFP-hs1 and DL4. Protein sam
emission spectra (between 450 & 600 nm) using fluorescence spectrophotostability of GFP [25,30,31]. The biophysical properties of
GFP-hs1 have been well studied and the protein was
evaluated to be highly stable as well as fold very efficiently
under various protein denaturation conditions [32-34]. In
above studies, DL4 and GFP-hs1 didn’t show any differ-
ence in their fluorescent properties at all, indicating that
the deletion of loop introduced to DL4 didn’t affect the
final global structure of GFP significantly. On the other
hand, protein folding and stability of GFP were more sen-
sitively affected by the introduced mutations according to
our previous studies [35]. Here, the refolding kinetics and
thermal stability of DL4 and GFP-hs1 were measured
and compared in order to study the influence of the loop
deletion in DL4 on the folding efficiency and stability of
GFP-hs1. An in vitro refolding kinetics of each protein
was performed using fluorescence spectrophotometer to
compare the folding rates of DL4 and GFP-hs1. The
protein samples were completely denatured by boiling
in presence of a chaotropic agent urea and the refolding
process was initiated by rapid dilution in PBS. The pro-
gression of protein refolding was examined by recording
the increase in fluorescence emission of the GFP vari-
ants (Figure 4). The refolding rate of DL4 was found to
be nearly similar to that of GFP-hs1.
The stabilities of deletion mutant DL4 and control
GFP-hs1 were investigated at different temperature.
Specifically, the thermal stability was evaluated by incubat-
ing both protein samples at temperatures between 70°C
and 90°C with 5°C increments for 30 min. The fluores-
cence remaining after heat treatment was measured using
filter fluorometer and plotted as a function of temperature.
As shown in Figure 5A, the activities of both DL4 and
GFP-hs1 were not changed at 70°C for 30 min, but DL4ples were scanned for excitation (between 400 & 550 nm) and
meter.
Table 1 Spectral and fluorescent properties of purified DL4 and GFP-hs1
Proteinsample Excitation peak (nm) Emission peak (nm) Quantum yield* Specific fluorescence Activity of purified proteins (a.u./μg)**
GFP-hs1 490 511 0.33 ± 0.02 5244.0 ± 237.69
DL4 490 511 0.33 ± 0.03 4978.5 ± 1062.78
*Average of three independent measurements represented with standard deviation.
**Average of two independent measurements represented with standard deviation.
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compared to GFP-hs1 from 75°C. In time-dependent assay
at 80°C, the fluorescence of DL4 was decreased much
faster than that of GFP-hs1 as incubation time increases
(Figure 5B). The inactivation constants of DL4 and GFP-
hs1 were estimated to be approximately 0.036 min−1 and
0.007 min−1, when we evaluated them using the first-order
inactivation model of GFP [36].
Overall, DL4 showed similar refolding kinetics, but
lower stability compared to GFP-hs1. These results in-
dicated that the deletion of loop sequence didn’t affect
the folding of GFP-hs1, but destabilized the protein
structure. Together with the similar spectral properties
of DL4 and GFP-hs1, all of these observations support
the hypothesis that DL4 may fold into its active native
structure through almost similar pathway of GFP-hs1,
but the native structure of DL4 might be unstable and
prone to form the native-like self-aggregating species.
The relation between the stability of DL4 and aggrega-
tion mechanism will be further discussed in Discussion
section.
Organization of DL4 in IBs
Misfolded protein mediated formation of IBs is generally
known to form amorphous structures [37]. On the otherFigure 4 Refolding kinetics of DL4 and GFP-hs1. The plot shows the re
complete denaturation in urea followed by renaturation initiated rapidly by
Normalized fluorescence in arbitrary units (au) was plotted against time inhand, it was confirmed that some IBs had amyloid-like
structures where inner molecules were relatively well-
ordered by intermolecular β-strand interactions [27]. We
examined whether the DL4 IBs composed of β-strand
rich GFP molecules had well-organized inner structures
by evaluating their amyloid-like structural properties.
For this, two representative amyloid-structure specific
assays were applied to the DL4 IBs.
The thioflavin T (ThT) assay is the most commonly
used method to check the presence of cross β-structure
conformation in amyloid-like structures. The ThT select-
ively binds to amyloid protein and shows increase in
fluorescence around 480 nm when excited at 450 nm
[38]. DL4 IBs were treated with ThT dye and the emis-
sion spectrum was scanned after exciting at 450 nm.
Insulin aggregates known to form amyloid-like structure
was also tested as a positive control [39]. As shown in
Figure 6, the intrinsic fluorescence of DL4 proteins
caused the increase of fluorescence for the DL4 aggre-
gates along the increase of emission wavelength, but
the emission spectra of DL4 aggregates with ThT or
without ThT exhibited no difference from 465 nm to
485 nm. The aggregated insulin proteins bound to ThT
showed clear increase in fluorescence compared to the
aggregates without ThT treatment. These results indicatedfolding progression curve of DL4 and GFP-hs1, measured after
dilution. Inset table shows the refolding rates of GFP variants.
seconds.
Figure 5 Thermal stability of DL4 and GFP-hs1. (A) Effect of various temperatures on the stability of DL4 and GFP-hs1. The stability was
measured by incubating at different temperatures for 30 minutes and the remaining fluorescence was plotted against temperature as function.
(Error bar – Standard deviation of three experiments). (B) Time-dependent temperature effect on the stability of DL4 and GFP-hs1 at 80°C. The
fluorescence at time zero min was taken as 100%. (Error bar – Standard deviation of two experiments).
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aggregates.
Proteolytic digestion of IBs containing amyloid-structure
generally yields the formation of amyloid fibrils, another
way to check the existence of amyloid-like structure [18].
To explore such structural morphology change of DL4
IBs, transmission electron microscopy (TEM) was also
employed. The electron micrograph of purified DL4 IBs
was found to display electron-dense, irregular sphere like
shape (Figure 7A). The IBs was treated with proteinase K,
which did not reveal any structural morphology pertaining
to amyloid fibril (Figure 7B). This also supported that the
DL4 IBs might not be an ordered amyloid-like conform-
ation, but disordered amorphous structure.Preparation of IB-based fluorescent nanoparticles
Fluorescent protein nanoparticles can be used in bio-
imaging, in vivo tracking of biomolecules and as tracers
for intravascular imaging [40,41]. Here, an attempt was
made to reduce the particle size of fluorescent DL4 IBs to
explore the possibility of utilizing the biologically active
DL4 IBs as fluorescent nanoparticles. This was attempted
by regulating the expression time of the recombinant pro-
tein at 37°C in E. coli. DL4 was expressed for 5 hours and
30 min, and the particle size distribution and structural
geometry of purified proteins were analyzed by dynamic
light scattering (DLS) and transmission electron micro-
scope (TEM). As shown in Figure 8A, the size of harvested
IBs after 5 hours of expression were in the range of 500 nm
Figure 6 Thioflavin T dye binding assay. Emission spectra of DL4 aggregates with and without ThT binding. The excitation wavelength was
450 nm. Inset shows the emission spectra of insulin aggregates with and without ThT binding as positive control.
Figure 7 Morphology of DL4 IBs before and after proteinase K
treatment. (A) Electron micrograph of purified DL4 IBs (scale bar
2 μm) (B) Electron micrograph of DL4 IBs after proteinase K
treatment. The scale bar depicts 1 μm.
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logical size of many bacterial inclusion bodies [11,42]. On
the other hand, the IBs from the cells expressing the DL4
for 30 min produced the particles around 100–200 nm
in diameter (Figure 8B). Specifically, the particle size
distribution of IBs by DLS analysis showed the reduc-
tion in size diameter from 400–600 nm to < ~200 nm
when the expression time was lowered from 5 hours to
30 min, as shown in bar diagram of Figure 8A & B. The
TEM results were roughly correlated with results of
DLS measurements, indicating the major population of
IBs produced at 5 hours and 30 min were around 500 nm
and 100–200 nm in diameter respectively. The functional
analysis of the DL4 IBs from 5 hours and 30 min expres-
sion by confocal microscopy also showed green fluores-
cence emission and exhibited distinct differences in their
particle size diameter (Figure 8C). These results suggested
that the size of bio-functional fluorescent DL4 IBs could
be reduced through simple modulation of expression times,
which might enable the preparation of fluorescent protein
nanoparticles.
Discussion
Active GFP IBs, potential fluorescent biomaterials, can
be simply achieved by over-expressing a GFP with low
folding efficiency in bacteria [14]. The GFP polypeptide
chains are generally misfolded, aggregated and deposited
to IBs. Such IBs exhibit fluorescence because correctly
folded active GFP molecules are aggregated together with
the misfolded proteins, but the major proteins in the IBs
are misfolded non-fluorescent proteins. The formation of
Figure 8 Fluorescent protein nanoparticles based on DL4 IBs. Particle sizes and fluorescent images of purified IBs were analyzed by electron
microscope, dynamic light scattering and confocal imaging. (A) Negative stained TEM image and DLS data of the purified DL4 expressed for
5 hours (B) Negative stained image and DLS data of purified DL4 expressed for 30 min. (Scale bar 2 μm). Inset figures show single IB of DL4
(scale bar 100 nm). (C) Confocal microscope images of the purified fluorescent DL4 particles expressed for 5 hours and 30 min (Scale bar 2 μm).
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be induced by fusing self-aggregating/assembling peptide
tags to GFP terminus [16,19]. In this study, we have
proposed another version of active GFP IBs induced by
the DL4, a GFP variant devoid of some loop residues. DL4
formed exclusively active IBs in E. coli through its intrinsic
self-aggregating property, and the IBs was confirmed to be
composed of mostly active fluorescent proteins. To our
knowledge, DL4 is the first GFP variant which forms
exclusively active intracellular IBs without any selective
peptide or protein tags for the self-aggregation/assembly.
Our study has indicated that the DL4 protein folds to
be its active form and the folded structures are aggregated
inside the cell. What induces the self-aggregation of the
folded DL4 proteins? In our previous study, the dynamic
nature of some exposed residues in DL4 structure wasconfirmed through molecular dynamics simulation [22].
Based on the results, we proposed that the introduced de-
letion mutation in DL4 marginally destabilized the folded
protein structure, which might induce the self-aggregation
of the folded protein. In the current study, DL4 showed
lower thermal stability compared to its native GFP, which
demonstrates the destabilization effect of deletion muta-
tion. This supports the hypothesis of destabilization effect
on the self-aggregation of DL4 indirectly. Further detailed
studies should be performed to understand the self-
aggregation mechanism of DL4 more exactly.
An impression from our study is that biologically active
IBs can be achieved through engineering a protein se-
quence itself. As mentioned in the introduction section,
active IBs have great potentials as biocatalysts and bioma-
terials. A major concern is how to generate such active
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generally relied on the protein’s natural property of active
aggregation or tagging some aggregating peptide/protein
sequences to the protein sequence [6,16]. Engineering of
protein sequence itself has not been seriously considered
to generate a mutant for active IBs presumably because
there might be a preconception that protein sequence en-
gineering which can induce the protein aggregation may
be possible only by inducing non-functional misfolded
proteins. On the other hand, the DL4 was generated by
deletion of GFP sequence, which suggests that we can
generate an active aggregating mutant through engin-
eering of a protein native sequence. Although it is quite
hard to generalize such sequence engineering approach
for the generation of active IBs, partial and marginal
destabilization of a target protein can be a way to generate
such mutants as discussed above.
In this study, it was demonstrated that fluorescent pro-
tein particles could be prepared by simply expressing the
DL4 in E. coli. The size of fluorescent IB particles could be
reduced up to around 100–200 nm by decreasing the DL4
expression time. However, the DL4-based protein particle
size needs to be further reduced to use them more effi-
ciently for real applications such as fluorescent nanotra-
cers. In fact, we tested the possibility whether the particle
size could be further reduced by lowering the expression
time or lowering the expression temperature further. The
problem in this attempt was that the produced fluorescent
IBs were too sticky to be handled, which hampered the
further characterization. The overcoming of this limitation
may facilitate the use of DL4-based particles.
Conclusions
In this study, we have studied various biophysical properties
of a GFP variant (DL4), and its IBs. It was demonstrated
that the DL4 was exclusively produced as active protein
aggregates under in vivo condition through its spontaneous
self-aggregation property. The intrinsic property of DL4 to
form aggregates in vivo was exploited to produce fluores-
cent protein particles with different sizes by modulating the
expression time. It is expected that DL4 IBs can be used as
fluorescent biomaterials. We also expect that DL4 can be
employed as a potential model protein to understand the
aggregation mechanism of native-like proteins present in
active IBs, which might give probable clues on the protein
aggregation related diseases.Additional file
Additional file 1: Figure S1. Amino acid sequences of GFP-hs1 and DL4
with His-tag at C-terminal end. Deletion of loop region of DL4 involves six
residues (GPVLLP) and they are highlighted in bold with yellow background
in primary sequence of GFP-hs1. An additional amino acid glutamine “Q”
has been placed after first amino acid methionine in both constructs.Competing interests
The authors declare that they have no competing interests.Authors’ contributions
GR and SL designed the research. GR, GM and HM performed the
experiments. GR, GM and SL analyzed the data and wrote the paper. HP,
SSAA, YK and SK provided the experimental and analytical tools and revised
the manuscript. All authors approved the final manuscript.Acknowledgements
This research was supported by Basic Science Program through the National
Research Foundation of Korea (NRF) funded by the Ministry of Education
(NRF- 2011–0021222).
Author details
1Department of Chemical Engineering, Pusan National University, Busan,
South Korea. 2Department of Polymer Science and Engineering, Pusan
National University, Busan, South Korea. 3Department of Bionanotechnology,
Gachon University, Seongnam, South Korea. 4Department of Molecular
Science and Technology, Ajou University, Suwon, South Korea. 5Department
of Biological Sciences, School of Life Sciences, Ulsan National Institute of
Science and Technology (UNIST), Ulsan, South Korea.
Received: 13 January 2014 Accepted: 11 May 2014
Published: 16 May 2014References
1. Villaverde A, Carrio MM: Protein aggregation in recombinant bacteria:
biological role of inclusion bodies. Biotechnol Lett 2003, 25:1385–1395.
LA - English.
2. Fink AL: Protein aggregation: folding aggregates, inclusion bodies and
amyloid. Fold Des 1998, 3:R9–R23.
3. Baneyx F, Mujacic M: Recombinant protein folding and misfolding in
Escherichia coli. Nat Biotechnol 2004, 22:1399–1408.
4. Esposito D, Chatterjee DK: Enhancement of soluble protein expression
through the use of fusion tags. Curr Opin Biotechnol 2006, 17:353–358.
5. Fink AL: Chaperone-mediated protein folding. Physiol Rev 1999,
79:425–449.
6. Borges P, Pacheco R, Karmali A: Pseudomonas aeruginosa amidase:
aggregation in recombinant Escherichia coli. Biotechnol J 2011, 6:888–897.
7. Nahalka J, Nidetzky B: Fusion to a pull-down domain: a novel approach of
producing Trigonopsis variabilisD-amino acid oxidase as insoluble
enzyme aggregates. Biotechnol Bioeng 2007, 97:454–461.
8. Huang Z, Zhang C, Chen S, Ye F, Xing X-H: Active inclusion bodies of acid
phosphatase PhoC: aggregation induced by GFP fusion and activities
modulated by linker flexibility. Microb Cell Fact 2013, 12:25.
9. Worrall DMGN: The formation of biologically active beta-galactosidase
inclusion bodies in Escherichia coli. Aust J Biotechnol 1989, 3:28–32.
10. Nahalka J, Mislovicova D, Kavcova H: Targeting lectin activity into
inclusion bodies for the characterisation of glycoproteins. Mol Biosyst
2009, 5:819–821.
11. Elena G-F, Joaquín S-F, Esther V, Antonio V: Tunable geometry of bacterial
inclusion bodies as substrate materials for tissue engineering. Nanotechnology
2010, 21:205101.
12. Vázquez E, Corchero JL, Burgueño JF, Seras-Franzoso J, Kosoy A, Bosser R,
Mendoza R, Martínez-Láinez JM, Rinas U, Fernández E, Ruiz-Avila L, García-Fruitós
E, Villaverde A: Functional inclusion bodies produced in bacteria as
naturally occurring nanopills for advanced cell therapies. Adv Mater
2012, 24:1742–1747.
13. Tsien RY: The green fluorescent protein. Annu Rev Biochem 1998, 67:509–544.
14. Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R: Engineering inclusion
bodies for non denaturing extraction of functional proteins. Microb Cell Fact
2008, 7:34.
15. Hsu S-TD, Blaser G, Jackson SE: The folding, stability and conformational
dynamics of beta-barrel fluorescent proteins. Chem Soc Rev 2009,
38:2951–2965.
16. Wu W, Xing L, Zhou B, Lin Z: Active protein aggregates induced by
terminally attached self-assembling peptide ELK16 in Escherichia coli.
Microb Cell Fact 2011, 10:9.
Raghunathan et al. Microbial Cell Factories 2014, 13:68 Page 11 of 11
http://www.microbialcellfactories.com/content/13/1/6817. Morell M, Bravo R, Espargaro A, Sisquella X, Aviles FX, Fernandez-Busquets X,
Ventura S: Inclusion bodies: specificity in their aggregation process and
amyloid-like structure. BBA-Mol Cell Res 2008, 1783:1815–1825.
18. Kim KR, Ahn K-Y, Park J-S, Lee KE, Jeon H, Lee J: Lyophilization and
enhanced stability of fluorescent protein nanoparticles. Biochem Biophys
Res Commun 2011, 408:225–229.
19. Garcia-Fruitos E, Gonzalez-Montalban N, Morell M, Vera A, Ferraz R, Aris A,
Ventura S, Villaverde A: Aggregation as bacterial inclusion bodies does
not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact
2005, 4:27.
20. MaHam A, Tang Z, Wu H, Wang J, Lin Y: Protein-based nanomedicine
platforms for drug delivery. Small 2009, 5:1706–1721.
21. Villaverde A: Bacterial inclusion bodies: an emerging platform for drug
delivery and cell therapy. Nanomedicine 2012, 7:1277–1279.
22. Raghunathan G, Soundrarajan N, Sokalingam S, Yun H, Lee S-G: Deletional
protein engineering based on stable fold. PLoS One 2012, 7:e51510. EP -.
23. Carrio MM, Cubarsi R, Villaverde A: Fine architecture of bacterial inclusion
bodies. FEBS Lett 2000, 471:7–11.
24. Bowden GA, Paredes AM, Georgiou G: Structure and morphology of
protein inclusion bodies in Escherichia Coli. Nat Biotechnol 1991,
9:725–730.
25. Pedelacq J-D, Cabantous S, Tran T, Terwilliger TC, Waldo GS: Engineering
and characterization of a superfolder green fluorescent protein.
Nat
Biotechnol 2006, 24:79–88.
26. Carrio M, Gonzalez-Montalban N, Vera A, Villaverde A, Ventura S:
Amyloid-like properties of bacterial inclusion bodies. J Mol Biol 2005,
347:1025–1037.
27. Wang L, Maji SK, Sawaya MR, Eisenberg D, Riek R: Bacterial inclusion
bodies contain amyloid-like structure. PLoS Biol 2008, 6:e195. EP.
28. de Groot NS, Sabate R, Ventura S: Amyloids in bacterial inclusion bodies.
Trends Biochem Sci 2009, 34:408–416.
29. Sabate R, Espargaro A, Saupe S, Ventura S: Characterization of the amyloid
bacterial inclusion bodies of the HET-s fungal prion. Microb Cell Fact 2009,
8:56.
30. Crameri A, Whitehorn EA, Tate E, Stemmer WPC: Improved green
fluorescent protein by molecular evolution using dna shuffling.
Nat Biotechnol 1996, 14:315–319.
31. Ito Y, Suzuki M, Husimi Y: A novel mutant of green fluorescent protein
with enhanced sensitivity for microanalysis at 488 nm excitation.
Biochem Biophys Res Commun 1999, 264:556–560.
32. Nagasundarapandian S, Merkel L, Budisa N, Govindan R, Ayyadurai N, Sriram
S, Yun H, Lee S-G: Engineering protein sequence composition for folding
robustness renders efficient Noncanonical amino acid incorporations.
ChemBioChem 2010, 11:2521–2524.
33. Raghunathan G, Sokalingam S, Soundrarajan N, Munussami G, Madan B, Lee
S-G: A comparative study on the stability and structure of two different
green fluorescent proteins in organic co-solvent systems. Biotechnol
Bioproc Eng 2013, 18:342–349. LA - English.
34. Soundrarajan N, Sokalingam S, Raghunathan G, Budisa N, Paik H-J, Yoo TH,
Lee S-G: Conjugation of proteins by installing bio-orthogonally reactive
groups at their n-termini. PLoS One 2012, 7:e46741. EP.
35. Raghunathan G, Sokalingam S, Soundrarajan N, Madan B, Munussami G, Lee
S-G: Modulation of protein stability and aggregation properties by
surface charge engineering. Mol Biosyst 2013, 9:2379–2389.
36. Vessoni Penna TC, Ishii M, Cholewa O, De Souza LC: Thermal characteristics
of recombinant green fluorescent protein (GFPuv) extracted from
Escherichia coli. Lett Appl Microbiol 2004, 38:135–139.
37. Wang L: Towards revealing the structure of bacterial inclusion bodies.
Prion 2009, 3:139–145.
38. Biancalana M, Koide S: Molecular mechanism of Thioflavin-T binding to
amyloid fibrils. BBA Proteins Proteom 1804, 2010:1405–1412.
39. Librizzi F, Foderà V, Vetri V, Lo Presti C, Leone M: Effects of confinement on
insulin amyloid fibrils formation. Eur Biophys J 2007, 36:711–715.
40. Seo H-S, Kim S-E, Park J-S, Lee J-H, Yang K-Y, Lee H, Lee KE, Han S-S, Lee J:
A three-dimensional nanostructured array of protein nanoparticles.
Adv Funct Mater 2010, 20:4055–4061.41. Ravnic DJ, Zhang Y-Z, Turhan A, Tsuda A, Pratt JP, Huss HT, Mentzer SJ:
Biological and optical properties of fluorescent nanoparticles developed
for intravascular imaging. Microsc Res Tech 2007, 70:776–781.
42. Upadhyay AK, Murmu A, Singh A, Panda AK: Kinetics of inclusion body
formation and its correlation with the characteristics of protein
aggregates in Escherichia coli. PLoS One 2012, 7:e33951. EP.
doi:10.1186/1475-2859-13-68
Cite this article as: Raghunathan et al.: A variant of green fluorescent
protein exclusively deposited to active intracellular inclusion bodies.
Microbial Cell Factories 2014 13:68.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
